Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

BACR & ECMC: Therapeutic interventions for cancer prevention /
Surrogate endpoint biomarkers in research

18th - 19th Jul 2016

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Submit
Thanks for rating
There has been a problem, please refresh and try again.
Published: 04.08.16
Views: 1567
Rating:

Dr Bernardo Bonanni – European Institute of Oncology, Milan, Italy

Dr Bonanni speaks with ecancertv at the 2016 BACR and ECMC Joint Meeting about "window of opportunity" trials which gauge pre-surgical patient responses to treatments against breast cancer.

He describes the range of medicines and dietary compounds which have shown chemopreventive activity, and how surrogate biomarkers can be brought to broader clincal application.

 

Previous conferences: highlights



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation